Loading clinical trials...
Loading clinical trials...
When faced with primary teeth affected by irreversible pulpitis or pulp necrosis, extraction is often the preferred option for practitioners, although validated alternatives exist, notably pulpectomy,...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Strasbourg, France
NCT07448571 · Apical Periodontitis, Periapical Diseases
NCT07340606 · Pulpitis - Irreversible
NCT07343804 · Cardiovascular Disease Risk Factor, Periapical Periodontitis
NCT07091981 · Postoperative Pain, Pulp Necrosis
NCT06843525 · Irreversible Pulpitis, Apical Periodontitis, and more
Service de Médecine et Chirurgie Bucco-dentaires - CHU de Strasbourg - France
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions